Anita Kåss, M D And Researcher, Keynote speaker at 37 ºC

37 ºC Life Science Technology Conference & Exhibition, Stavanger Forum in Norway, 6-7 June 2017.
37 ºC is an international business platform for industry and innovation.
DESCRIPTION:
M.D. Anita Kåss developed a new drug that is licenced to a Japanese pharmaceutical company for 800 million NOK. The medicine treats arthritis, psoriasis and MS. This is the largest license agreement made by a Norwegian hospital to date.

[@kirstycollins4850]

Thank you so much for posting this! I have been looking for research in autoimmune diseases since I was diagnosed with Cogans syndrome which has made me deaf.

[@bennguyen1313]

What is the link between hormones and rheumatoid arthritis in men?